1-Oct-2025 To study treatment resistance in high-grade serous ovarian cancer, MSK researchers develop new approach Memorial Sloan Kettering Cancer Center Peer-Reviewed Publication A Memorial Sloan Kettering research team aims to find new ways to stop the most common and deadly form of ovarian cancer — high-grade serous ovarian cancer — from recurring with the help of a method they developed for tracking the evolution of treatment resistant cells in ovarian cancer using blood tests. Journal Nature Funder Ovarian Cancer Research Alliance, NIH/National Institutes of Health, NIH/National Cancer Institute, Cancer Research U.K. Cancer Grand Challenges Program
1-Oct-2025 Peptide study paves path toward new weapon against antibiotic-resistant bacteria Oregon State University Peer-Reviewed Publication New research into antimicrobial peptides, small chains of amino acids able to damage bacterial cells, shows why some peptides are more effective at doing that and also why some cells are more vulnerable. Journal Proceedings of the National Academy of Sciences Funder NIH/National Institutes of Health
1-Oct-2025 Groundbreaking study finds variations in the donor human milk critical for many preterm infants worldwide University of North Carolina at Greensboro Peer-Reviewed Publication A landmark international study published in the American Journal of Clinical Nutrition has revealed significant variations in the nutritional composition of donor human milk across different countries. These findings could transform how hospitals support critically ill preterm infants worldwide. Journal American Journal of Clinical Nutrition Funder NIH/Eunice Kennedy Shriver National Institute of Child Health and Human Development
1-Oct-2025 Body’s garbage-collecting cells protect insulin production in pancreas WashU Medicine Peer-Reviewed Publication Researchers at WashU Medicine have discovered that certain immune cells in the pancreas, called macrophages, can protect insulin-producing cells and prevent Type 1 diabetes in mice. Journal Nature Funder NIH/National Institute of Allergy and Infectious Diseases
1-Oct-2025 ALS appears to be an autoimmune disease La Jolla Institute for Immunology Peer-Reviewed Publication The researchers discovered that inflammatory immune cells, called CD4+ T cells, mistakenly target certain proteins that are part of the nervous system in people with ALS. This kind of "self-attack" is the defining feature of autoimmune disease. Journal Nature Funder LJI & Kyowa Kirin, Inc. (KKNA- Kyowa Kirin North America), Swedish Research Council, Freedom Together Foundation, NIH/National Institute of Neurological Disorders and Stroke